January 31st, 2012
Guiding TAVR into Clinical Practice
Steven Bailey, MD, Richard A. Lange, MD, MBA and L. David Hillis, MD
The ACC, AATS, SCAI, and STS have issued a critical consensus document to guide the use of transcatheter aortic valve replacement (TAVR) as it enters clinical practice in the U.S. (see also our CardioExchange news coverage here). CardioExchange Interventional Cardiology moderators Rick Lange and David Hillis posed the following questions to writing committee member Steven R Bailey, the Janey Briscoe Distinguished Professor of […]
April 3rd, 2011
PARTNER B Substudy Examines Cost-Effectiveness of TAVI
Larry Husten, PHD
Transcatheter aortic valve implantation (TAVI) is about as cost-effective as other common cardiovascular procedures, according to results of the PARTNER B cost-effectiveness substudy, which were presented today at the American College of Cardiology meeting in New Orleans. (The main results of PARTNER B, which studied the safety and efficacy of TAVI in patients with severe […]
NEJM Journal Watch — Recent Cardiology Articles- Atorvastatin vs. Rosuvastatin: Do Effectiveness and Safety Differ?
- Which Patients with Cardiogenic Shock Are at Risk for Early Death?
- Cardiac Magnetic Resonance Imaging for Risk Stratification in Nonischemic Cardiomyopathy
- Evidence Mounts for Triple Single-Pill Combination Therapy for Hypertension
- Atherosclerosis Burden and Progression on Imaging and Associated Mortality in Asymptomatic Patients